PEARLS AND POINTERS ON MANAGING PARATHYROID DISEASE
Educational Objectives
| The goal of this program is to improve the management of para-thyroid disease. After hearing and assimilating this program,
the clinician will be better able to:
|
 | Employ diagnostic testing to distinguish secondary from primary hyperparathyroidism (PHPT).
|
 | Utilize the criteria for surgical intervention in PHPT.
|
 | Discuss the similarities and differences between bilateral and unilateral exploration of the parathyroid gland.
|
 | Practice the techniques commonly used in conventional bilateral exploration of the parathyroid.
|
 | Recognize and manage patients with persistently elevated parathyroid hormone after surgery.
|
Faculty Disclosure
In adherence to ACCME Standards for Commercial Support, Audio-Digest requires all faculty and members of the planning
committee to disclose relevant financial relationships within the past 12 months that might create any personal conflicts of interest.
Any identified conflicts were resolved to ensure that this educational activity promotes quality in health care and not a
proprietary business or commercial interest. For this program, the following has been disclosed: Dr. Heller has received educational
grants and is on the Speakers Bureau of Genzyme. Dr. Cohen and the planning committee reported nothing to disclose.
Ackowledgements
Dr. Cohen was recorded at Minimally Invasive and Conventional Surgical Management of Thyroid and Parathyroid
Disorders, held April 18-19, 2008, in Augusta, GA, and sponsored by the Medical College of Georgia, Division of
Continuing Education and University of Pisa. Dr. Keller was recorded at Surgery of the Thyroid and Parathyroid
Glands, held November 7-9, 2008, in Boston, MA, and sponsored by Harvard Medical School, Department of Continuing
Education. The Audio-Digest Foundation thanks the speakers and the sponsors for their cooperation in the
production of this program.
Management Guidelines
James Cohen, MD, PhD, Professor of OtolaryngologyHead and Neck Surgery, Multidisciplinary Thyroid and Parathyroid
Tumor Program, Oregon Health and Science University, Portland
| Role of surgery: successful surgical treatment of primary hyperparathyroidism (PHPT) requires secure diagnosis and understanding
of indications for surgery (means understanding natural history and consequences of disease); 3 questions to
askfirst, whether patient has PHPT; second, whether patient has indications for surgery; third, localization; previously
(before routine screening performed), most patients seen with PHPT had manifestations of disease (indications for surgery;
eg, bone disease, renal stones); previously, only bilateral exploration performed
|
| Basic diagnostic testing: includes ionized calcium (Ca) and intact parathyroid hormone (PTH; 7-84 assay); ensure that patient
has nonphysiologic secretion of PTH; possible for patient to have normal PTH and normal Ca but out of proportion to
one another; caution necessary in area of overlap between PHPT and secondary HPT; other tests25-hydroxyvitamin D
level, which reflects dietary intake; vitamin D deficiencyrampant, due to inadequate sun exposure and diet and coexistent
in most patients with PHPT; important to treat before surgery so patient can optimally absorb Ca after surgery; ensure
that serum urea nitrogen (BUN) and creatinine not contributing to secondary HPT; occasionally, creatinine clearance necessary;
24-hr urine Cato rule out benign familial hypocalciuric hypercalcemia (BFHH) or other forms of secondary
HPT; extremely low 24-hr urine Ca may mean presence of BFHH, poor Ca intake, or deficiency in vitamin D causing poor
absorption of Ca; extremely elevated 24-hr urine Ca may signify spillover due to PHPT or renal wasting of Ca; if unable to
distinguish, temporary trial of thiazide diuretic to decrease Ca excretion and determine whether PTH suppressed (secondary
HPT): signs and symptoms of PHPTabsent in majority of patients; study shows that 75% of patients with mild
HPT who are asymptomatic by usual criteria will not necessarily progress over time; 25% progress, so monitoring necessary
|
| Primary hyperparathyroidism: renal consequencesrenal stones relatively uncommon (15%-20%) in PHPT and indication
for surgery; hypercalciuria seen in 30% to 50% of patients and defined as urine Ca >350 to 400 mg/24 hr; no correlation
between urinary Ca and presence of renal stones; formation of renal stones complex process; over time,
hypercalcemia and hypercalciuria impair renal function; bone consequencesexcess of PTH affects cortical bone; standard
screening for osteoporosis looks at lumbar spine and hip; bone mineral density (BMD) reported as T score (number
of SDs from normal); lumbar spine, however, mostly cancellous bone, and PTH has protective effect on cancellous bone,
so not ideal site to look for BMD changes related to PTH; radius (40%-50% cortical bone) ideal site to look for effects of
excess PTH; screening for BMD necessary; if BMD decreased, determine whether differentially greater in radius than hip
or lumbar spine (useful since many patients older and have osteoporosis for other reasons); BMD testing part of work-up
|
| Surgical management: advantageous for bones in patients with bone changes from PHPT; patients who are cured of disease
and who take added Ca and vitamin D can increase BMD 10% within first year of surgery, and bone loss stops; also
results in 0% incidence of recurrent nephrolithiasis
|
| Other consequences of PHPT: musculoskeletal pain and bone pain; increased cardiovascular risk, with possible increased
incidence of sudden death; in patients with secondary HPT from renal causes or chronic PHPT, proximal muscle weakness
and band keratopathy; not conclusive that peptic ulcer disease associated with PHPT or that hypertension exacerbated
by PHPT; no link established between PHPT and refractory pancreatitis, gout, and anemia; fatigue, weakness, and
depression possibly associated
|
| Criteria for surgical intervention: serum Ca >1 mg/dL above normal range (patients more likely to have dehydration and
worsening hypercalcemia); 24-hr urine Ca >400 mg/24 hr; creatinine clearance <30% of age-matched patients; previously,
BMD Z score (age-matched number of SDs from normal) 2 SDs below age-matched normal; presently, T score (number of
SDs below normal bone) 2.5 times below normal (increased risk for fracture) or decreasing BMD, despite maximum Ca and
vitamin D intake; age <50 yr; complications of PHPT or patients who cannot be reliably followed; asymptomatic patients
with PHPT must be followed with vitamin D or Ca levels once or twice annually after stabilization, urine Ca initially and
BMD every 8 to 12 mo; absolute vs relative indicationssurgery not performed if patient has severe medical comorbidities
or if against patients wishes; decision difficult if patient has multiple relative indications; decision influenced by surgeons
vs patients expectations and by progression of disease
|
| Preoperative localization: if glands well localized, surgery likely straightforward and successful, and should be performed;
secure localization last of 3 questions
|
Conventional Parathyroidectomy
Dr. Cohen
| Definitions: bilateral exploration involves 4 glands; unilateral exploration involves 2 glands on one side of neck; targeted or
directed parathyroidectomy involves only one gland; 2 conventional methods include 1) open approach and 2) endoscopic
or video-assisted; minimally invasive does not imply use of endoscope, only that overall morbidity less than that of
conventional approach; strategy for any parathyroid operation to identify and remove all abnormal tissue; change seen in
how abnormal tissue identified; abnormal tissue now identified before patient taken to operating room (OR)
|
| Bilateral exploration: requires great judgment and experience for success; parathyroid glands difficult to locate (look similar
to surrounding fat, particularly if some blood staining present) and have variable location; in HPT, normal glands often
suppressed (smaller and less vascular); frozen sections not helpful; should ask pathologist only whether tissue is
parathyroid; differentiation between normal and abnormal gland by frozen sections extremely difficult; macroscopic appearance
of gland relied on to make decision in OR; decision not easy when gland only slightly abnormal; bilateral exploration
relies on surgical experience to locate gland and surgical judgment to determine abnormality
|
| Unilateral exploration: 85% to 95% of patients have problem in only one gland; removal of one gland and finding normal
gland precludes 4-gland hyperplasia; less morbidity and less risk for recurrent laryngeal nerve injury; requires preoperative
localization to determine on which side of neck to operate; requires heavy reliance on surgical experience and judgment
|
| Functional studies: intraoperative PTH assay determines PTH level in OR; if PTH level returns to normal, means abnormal
tissue removed; alternative gamma probe, which relies on radionuclide uptake by tissue and absence when tissue removed to
make same judgment; led to targeted parathyroidectomy; all operations based on conventional parathyroidectomy
|
| Parathyroid surgery: steep learning curve; finding normal gland difficult; more difficult second time; start and finish one
side of neck before working on other side; localization relies heavily on bloodless field; loop magnification used; understanding
embryonic roots of parathyroid important, particularly in pediatric patients; based on good exposure, which depends
on ability to visualize field by anterior and superior retraction of ipsilateral thyroid lobe (to get into paratracheal
and thyroid bed)
|
| Speakers technique for conventional bilateral exploration: incision based just below thyroid isthmus, usually at inferior
pole; incision usually ≈3.5 cm; action on strap muscles depends on location of gland; for patient with low parathyroid
adenoma, traction obtained by taking sternothyroid muscle and retracting entire laryngotracheal complex upward
|
 | Position of parathyroid adenoma: determines actions taken; if adenoma at level of sternal notch, section both strap muscles;
if strap muscles pulled laterally, distance comes from stretch of strap muscles and from pulling hyoid bone down;
if exploring thymic tongue with open technique, strap muscles problematic
|
 | Finding inferior gland: first look below thyroid pole; when field maximally exposed with retraction of strap muscles, look
around inferior pole of thyroid; parathyroid adenoma often behind draining veins from thyroid; should also look for
thyrothymic ligament and thymic tongue; follow ligament upward to where it joins inferior aspect of thyroid lobe, and
inferior parathyroid almost always sits on that tract; exercise caution about not placing clamp on parathyroid adenoma
|
 | Finding superior gland: thyroid is handle for getting into paratracheal groove and into posterior aspect of thyroid; necessary
to mobilize thyroid gland; middle layer of deep cervical fascia sends its investments from thyroid to carotid sheath;
incise fascia as high as possible to roll gland forward to obtain good exposure of its posterior aspect; if patient has short
neck or big gland, moving gland forward important, as well as taking down superior pole if necessary to obtain exposure;
most parathyroid glands located superior and lateral to recurrent laryngeal nerve and inferior thyroid artery cross or
to where nerve inserts into larynx; in conventional exploration, should locate recurrent laryngeal nerve, especially if
dealing with superior gland; probably not applicable in targeted parathyroidectomy if involving inferior gland located
anteriorly in thymic tongue; recurrent laryngeal nerve useful landmark in guiding exploration; inferior gland sits anterior
to coronal plane, and superior gland sits posterior to plane; as gland pulled forward, plane shifts
|
 | If gland not found after inferior and superior exploration: explore thymic tongue as far down as possible; anterior mediastinal
exploration not arbitrary removal of block of fat from anterior or superior mediastinum; plane of recurrent laryngeal
nerve important in determining where to explore; vascular pedicles important for gland localization; if still unable
to locate abnormal gland, explore carotid sheath (open and search); parathyroid adenomas usually located in proximity
to vagus nerve; as last resort, thyroid lobe removed if other side explored and gland(s) not found
|
| Biopsy: whether to biopsy normal glands to prove them normal controversial, due to morbidity of bilateral exploration and
risk for hypoparathyroidism (although usually temporary); routine biopsy of gland not necessary, except if exploration unsuccessful;
in all decision making, treat every parathyroid gland as last one; should not make final decision about excision
until involvement of other glands determined; operative noteshould reflect actions performed, findings, and tissues
sent, based on frozen section, particularly in unsuccessful exploration
|
PTH Elevation After Parathyroid Surgery
Keith S. Heller, MD, Professor of Surgery, New York University School of Medicine, and Chief, Division of Endocrine
Surgery, New York University, Langone Medical Center, New York, NY
| Persistently elevated PTH: incidence 10% to 40% and same whether bilateral or focused exploration performed; article by
Silverbergpatients seen in referral center with normocalcemic PHPT have more substantial skeletal involvement than typically
seen in PHPT and develop more symptoms and complications over time; may represent earliest form of symptomatic
PHPT; relatively normal Ca does not mean that PHPT relatively insignificant; explanationsmost common one states that
actually reactive secondary HPT after surgery, particularly in northern parts of country, where vitamin D deficiency almost
rule, not exception; in some patients, impaired renal hydroxylation of vitamin D proposed; other studies demonstrate decreased
peripheral sensitivity to PTH; speakers concern whether patients actually have persistent PHPT and whether disease
significant; if due to vitamin D deficiency and bone re-mineralization, expected that over time, persistent elevations of PTH
would resolve; study datashow that 50% to almost 100% of patients return to normal; in group with persistent elevation,
3% developed frank recurrent disease with hypercalcemia; small series showed that 14% with persistently elevated PTH developed
recurrent HPT; in 3 other studies with similar design, in which intraoperative PTH measured, no intraoperative decisions
made based on measurements; on bilateral exploration, 15% of patients had multigland disease which would have been
missed by imaging and intraoperative PTH measurement
|
| Speakers study: 816 participants; all had preoperative sestamibi scanning and intraoperative PTH measurements; criteria
for persistently elevated PTH calcium 10.2 mg/dL and PTH >65 pg/mL at postoperative visits; 2% failure rate, with all
having persistently elevated postoperative Ca and PTH, despite fact that imaging showed one abnormal gland and intraoperative
PTH met criterion of 50% drop into normal range; 15% had normocalcemic elevated PTH postoperatively;
compared to groups cured postoperatively, group with persistently elevated PTH tended to have elevated (50% higher)
preoperative PTH level, less likely to have undergone bilateral exploration, and less likely to have multiple abnormal
glands identified; final intraoperative PTH slightly higher in group with persistently elevated PTH; postoperatively,
slightly lower Ca level in PHPT group and statistically significant lower vitamin D levels; some patients clearly had secondary
form of HPT postoperatively; group with persistently elevated PTH divided into those with low-normal Ca (<9.6
mg/dL) and those with high-normal Ca, with no difference found; group whose PTH normalized tended to have Ca that
increased more, compared to group with persistently elevated PTH (also true for vitamin D); in group with normal Ca and
PTH postoperatively, none developed recurrent HPT, although some developed slightly elevated PTH levels; no patients
with persistently elevated PTH but relatively low Ca went on to develop recurrent disease; 3 of 47 developed frank HPT if
Ca levels higher normal
|
| Speakers more recent study: 176 participants with PHPT; 70% underwent focused single-gland exploration, 7% unilateral
exploration, and 15% bilateral exploration, based on imaging; 7% started as focused exploration but converted to bilateral
exploration because intraoperative PTH did not decrease; ≈15% of patients with PHPT have multigland disease,
but imaging studies detect only ≈ 50% of these; outcome11% had persistently elevated PTH; final intraoperative
PTHin group with PTH <10 pg/mL (14%), none had persistently elevated PTH postoperatively; in group with PTH
<20 pg/mL, 2 had persistently elevated PTH postoperatively but had low Ca levels; as numbers increase, percentage of
patients with persistently elevated PTH increases (all met 50% criteria); in group with PTH >40 pg/mL, approximately
one-third had persistently elevated PTH and in 4 of 7, Ca in high range; possible way of selecting patients who require
more careful follow-up; conclusionsimportant to follow PTH; in most cases, persistently elevated PTH related to vitamin
D deficiency; concern about patients who have high-normal Ca; high final intraoperative PTH possibly more accurate
predictor of persistent disease than 10-min intraoperative PTH; follow patients BMD (shown that if HPT improved,
BMD improves)
|
Suggested Reading
Beyer TD et al: Parathyroidectomy outcomes according to operative approach. Am J Surg 193:368, 2007; Chen H et al: Intraoperative
parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery
138:583, 2005; Chiu B et al: Which intraoperative parathyroid hormone assay criterion best predicts operative success? A
study of 352 consecutive patients. Arch Surg 141:483, 2006; de Vos tot Nederveen Cappel R et al: Novel criteria for parathyroid
hormone levels in parathyroid hormone-guided parathyroid surgery. Arch Pathol Lab Med 131:1800, 2007; Gianotti L et
al: A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J Clin Endocrinol
Metab 91:3011, 2006; Gil-Cárdenas A et al: Is intraoperative parathyroid hormone assay mandatory for the success of targeted
parathyroidectomy? J Am Coll Surg 204:286, 2007; Lew JI et al: Role of intraoperative parathormone monitoring during
parathyroidectomy in patients with discordant localization studies. Surgery 144:299, 2008; Lombardi CP et al: Parathyroid
hormone levels 4 hours after surgery do not accurately predict post-thyroidectomy hypocalcemia. Surgery 140:1016, 2006; Riss
P et al: A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery
142:398, 2007; Siperstein A et al: Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound,
sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420, 2008; Solorzano CC et
al: Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic
primary hyperparathyroidism. Arch Surg 143:659, 2008; Sugg SL et al: Detection of multiple gland primary hyperparathyroidism
in the era of minimally invasive parathyroidectomy. Surgery 136:1303, 2004; Suh JM et al: Primary hyperparathyroidism:
is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908, 2008; Wang TS et al: Persistently elevated
parathyroid hormone levels after parathyroid surgery. Surgery 138:1130, 2005; Westerdahl J et al: Unilateral versus bilateral
neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg
246:976, 2007; Yen TW et al: The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism.
Surgery 140:665, 2006.
|